ID LINK | NAME | STRUCTURE CAS | CLOGP | CLOGS | MW | THERAPEUTIC AREA |
---|---|---|---|---|---|---|
FDBD00069 | Flunisolide |
![]() 3385-03-3 |
2.627 | -3.014 | 434.498 | For the maintenance treatment of asthma as a prophylactic therapy. |
FDBD00070 | Baclofen |
![]() 1134-47-0 |
1.873 | -2.288 | 213.661 | For the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. |
FDBD00071 | Amphetamine |
![]() 300-62-9 |
1.942 | -2.090 | 135.206 | For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children. |
FDBD00072 | Pentagastrin |
![]() 5534-95-2 |
3.825 | -7.198 | 767.891 | Used as a diagnostic aid for evaluation of gastric acid secretory function. |
FDBD00073 | Nicotine |
![]() 1954/11/5 |
1.885 | -2.011 | 162.232 | For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation. |
FDBD00074 | Cevimeline |
![]() 107233-08-9 |
1.837 | -1.477 | 199.313 | For the treatment of symptoms of dry mouth in patients with Sjögren's Syndrome. |
FDBD00075 | Lorazepam |
![]() 846-49-1 |
3.915 | -5.064 | 321.158 | For the management of anxiety disorders, and for treatment of status epilepticus. |
FDBD00076 | Esmolol |
![]() 81147-92-4 |
2.720 | -3.568 | 295.374 | For the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. Also used in noncompensatory sinus tachycardia where the rapid heart rate requires specific intervention. |
FDBD00077 | Bortezomib |
![]() 179324-69-7 |
0.125 | -3.515 | 384.237 | For treatment of multiple myeloma in patients who have not been successfully treated with at least two previous therapies. |
FDBD00078 | Ethchlorvynol |
![]() 113-18-8 |
1.638 | -0.911 | 144.599 | Used for short-term hypnotic therapy in the management of insomnia for periods of up to one week in duration; however, this medication generally has been replaced by other sedative-hypnotic agents. |
2911 ,
292